SEC Form 4 · accession 0001209191-15-066803
Bone Biologics Corp · BBLG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Jeff Frelick
Officer — Chief Operating Officer
Period of report
Aug 17, 2015
Accepted (ET)
Aug 19, 2015 · 12:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001419554
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $1.58 | Aug 17, 2015 | A | 1,040,596 | A | — | Aug 17, 2025 | Common Stock | 1,040,596 | 1,040,596 | D |
Explanation of responses
- F1The options shall vest and become exercisable in three equal installments on each of June 8, 2016, June 8, 2017 and June 8, 2018.